
Schneeberger
Facing ongoing competitive pressures and market growth demands, life science and biomedical original equipment manufacturers (OEMs) must constantly deliver new advancements in technology, processes, workflows, and production. But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against the in-use failures of their advanced equipment.
In the case of advanced instruments used in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component – in-process linear motion systems – can generate consequences ranging from inconvenient to catastrophic.
This white paper highlights how next-generation linear motion systems can be specified, designed, installed, and maintained to both advance life science and biomedical capital equipment manufacturing – and ensure against failures of any consequence.
Latest from Today's Medical Developments
- Happy Independence Day - July 4th
- ROLLON celebrates 50 years and future growth with opening of new Michigan facility
- Explore the future of CT scanning with Nikon's Limited Angle CT innovation
- Eagle Machine, part of the YCM Alliance, announces Demo Days August 20-21
- Unlocking the power of direct torque control in cobots
- Shopfloor Connectivity Roundtable with Renishaw & SMW Autoblok
- Tekniplex Healthcare opens state-of-the-art facility in Madison
- Maximize efficiency with FAULHABER's latest motor technology